Literature DB >> 3135128

Evidence that defective gamma interferon production in patients with primary immunodeficiencies is due to intrinsic incompetence of lymphocytes.

R Paganelli1, M R Capobianchi, B Ensoli, G P D'Offizi, J Facchini, F Dianzani, F Aiuti.   

Abstract

We have selected 11 patients with primary immunodeficiency disorders predominantly affecting T lymphocyte function (four with ataxia-telangiectasia (AT), four with common variable immunodeficiency (CVI) and one each with Wiskott-Aldrich syndrome, hyper-IgE syndrome and combined immunodeficiency) with defective gamma interferon (IFN-gamma) production in vitro. Induction with phytohaemagglutinin showed low interleukin 2 (IL-2) production concomitant with reduced IFN-gamma titres. However the addition of 10 U/ml of rIL-2 to cultures stimulated with staphylococcal enterotoxin B or galactose oxidase failed to restore IFN-gamma production in defective cases. IFN-gamma was titrated by both bioassay and immunoradiometric assay, ruling out the possible release of inactive or altered IFN-gamma molecules. Normal levels of IFN-gamma were found in patients of patients with AT, as well as in two AT and two CVI cases, demonstrating heterogeneity of defects within these syndromes. Soluble inhibitors or cellular suppression of IFN-gamma were not observed in mixing experiments. The possibility that defective interaction between accessory cells and T lymphocytes might account for the poor response to the inducing agents was ruled out as no IFN-gamma was produced using a calcium ionophore--which bypasses this step--in seven patients with absolute IFN-gamma deficiency.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3135128      PMCID: PMC1541514     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

Review 1.  The human interleukin-2 receptor.

Authors:  W C Greene; W J Leonard
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

2.  Human immune interferon: induction in lymphoid cells by a calcium ionophore.

Authors:  F Dianzani; T M Monahan; J Georgiades; J B Alperin
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

3.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

4.  Relationship between IL 2 synthesis and the proliferative response to PHA in different primary immunodeficiencies.

Authors:  M López-Botet; G Fontán; M C Garcia Rodriguez; M O de Landázuri
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

5.  Genetic heterogeneity in ataxia-telangiectasia studied by cell fusion.

Authors:  N G Jaspers; D Bootsma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

6.  Interleukin 2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes.

Authors:  G H Reem; N H Yeh
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

7.  Impaired production of interleukins in patients with cell-mediated immunodeficiencies.

Authors:  R Paganelli; F Aiuti; P C Beverley; R J Levinsky
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

8.  Heterogeneity of immunological abnormalities in ataxia-telangiectasia.

Authors:  M Fiorilli; L Businco; F Pandolfi; R Paganelli; G Russo; F Aiuti
Journal:  J Clin Immunol       Date:  1983-04       Impact factor: 8.317

9.  Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets.

Authors:  T Kasahara; J J Hooks; S F Dougherty; J J Oppenheim
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

10.  Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.

Authors:  J W Kappler; B Skidmore; J White; P Marrack
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  7 in total

1.  Spontaneous and oxidative stress-induced programmed cell death in lymphocytes from patients with ataxia telangiectasia (AT).

Authors:  R Schubert; J Reichenbach; N Royer; M Pichler; S Zielen
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

2.  In vivo modulation of cytokine synthesis by intravenous immunoglobulin.

Authors:  W A Sewell; M E North; R Cambronero; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

3.  Impaired interferon-gamma production in response to live bacteria and Toll-like receptor agonists in patients with ataxia telangiectasia.

Authors:  J Reichenbach; R Schubert; J Feinberg; O Beck; M Rosewich; M A Rose; S Zielen
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

4.  Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency.

Authors:  N Rezaei; A A Amirzargar; Y Shakiba; M Mahmoudi; B Moradi; A Aghamohammadi
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

5.  Deficiencies in CD4+ and CD8+ T cell subsets in ataxia telangiectasia.

Authors:  R Schubert; J Reichenbach; S Zielen
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

6.  Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications.

Authors:  Nima Rezaei; Mostafa Haji-Molla-Hoseini; Asghar Aghamohammadi; Ali Akbar Pourfathollah; Mina Moghtadaie; Zahra Pourpak
Journal:  J Clin Immunol       Date:  2007-10-03       Impact factor: 8.317

7.  Selective deficiency of interferon-gamma production in the hyper-IgE syndrome. Relationship to in vitro IgE synthesis.

Authors:  R Paganelli; E Scala; M R Capobianchi; E Fanales-Belasio; G D'Offizi; M Fiorilli; F Aiuti
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.